HKSE - Delayed Quote • HKD
Alibaba Health Information Technology Limited (0241.HK)
At close: April 26 at 4:08 PM GMT+8
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
28,218,447.000
26,763,016.000
20,577,616.000
15,518,468.000
Cost of Revenue
21,949,101.000
21,061,682.000
16,469,623.000
11,901,219.000
Gross Profit
6,269,346.000
5,701,334.000
4,107,993.000
3,617,249.000
Operating Expense
5,929,102.000
5,650,088.000
5,126,839.000
3,506,424.000
Operating Income
340,244.000
51,246.000
-1,018,846.000
110,825.000
Net Non Operating Interest Income Expense
384,470.000
325,755.000
206,023.000
162,966.000
Pretax Income
858,290.000
550,994.000
-252,514.000
401,219.000
Tax Provision
42,393.000
16,731.000
13,427.000
58,539.000
Net Income Common Stockholders
817,104.000
533,407.000
-265,555.000
348,588.000
Diluted NI Available to Com Stockholders
817,104.000
533,407.000
-265,555.000
348,588.000
Basic EPS
0.06
0.04
-0.02
0.03
Diluted EPS
0.06
0.04
-0.02
0.03
Basic Average Shares
13,505,062.694
13,503,050.886
13,482,634.084
13,245,718.572
Diluted Average Shares
13,557,053.415
13,541,579.646
13,482,634.084
13,326,524.675
Total Expenses
27,878,203.000
26,711,770.000
21,596,462.000
15,407,643.000
Net Income from Continuing & Discontinued Operation
817,104.000
533,407.000
-265,555.000
348,588.000
Normalized Income
647,901.550
421,613.530
-673,309.000
231,037.470
Interest Income
389,394.000
331,588.000
209,838.000
165,415.000
Interest Expense
4,924.000
5,833.000
3,815.000
2,449.000
Net Interest Income
384,470.000
325,755.000
206,023.000
162,966.000
EBIT
863,214.000
556,827.000
-248,699.000
403,668.000
EBITDA
916,261.000
620,546.000
-188,123.000
443,294.000
Reconciled Cost of Revenue
21,949,101.000
21,061,682.000
16,469,623.000
11,901,219.000
Reconciled Depreciation
53,047.000
63,719.000
60,576.000
39,626.000
Net Income from Continuing Operation Net Minority Interest
817,104.000
533,407.000
-265,555.000
348,588.000
Total Unusual Items Excluding Goodwill
177,994.000
115,251.000
543,672.000
137,486.000
Total Unusual Items
177,994.000
115,251.000
543,672.000
137,486.000
Normalized EBITDA
738,267.000
505,295.000
-731,795.000
305,808.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
8,791.550
3,457.530
135,918.000
19,935.470
3/31/2021 - 3/22/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade